GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Beginning Cash Position

Neuroscientific Biopharmaceuticals (ASX:NSB) Beginning Cash Position : A$4.91 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals Beginning Cash Position?

Neuroscientific Biopharmaceuticals's Beginning Cash Position for the quarter that ended in Dec. 2023 was A$4.91 Mil.

Neuroscientific Biopharmaceuticals's quarterly Beginning Cash Position declined from Dec. 2022 (A$7.22 Mil) to Jun. 2023 (A$3.33 Mil) but then increased from Jun. 2023 (A$3.33 Mil) to Dec. 2023 (A$4.91 Mil).

Neuroscientific Biopharmaceuticals's annual Beginning Cash Position increased from Jun. 2021 (A$3.29 Mil) to Jun. 2022 (A$14.16 Mil) but then declined from Jun. 2022 (A$14.16 Mil) to Jun. 2023 (A$7.22 Mil).


Neuroscientific Biopharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Beginning Cash Position Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Beginning Cash Position
0.10 4.61 3.29 14.16 7.22

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.16 9.50 7.22 3.33 4.91

Neuroscientific Biopharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Neuroscientific Biopharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Traded in Other Exchanges
N/A
Address
85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines